Ronald A. Asherson

444 total citations
20 papers, 212 citations indexed

About

Ronald A. Asherson is a scholar working on Hematology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ronald A. Asherson has authored 20 papers receiving a total of 212 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 3 papers in Surgery and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ronald A. Asherson's work include Platelet Disorders and Treatments (4 papers), Immune Cell Function and Interaction (3 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). Ronald A. Asherson is often cited by papers focused on Platelet Disorders and Treatments (4 papers), Immune Cell Function and Interaction (3 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). Ronald A. Asherson collaborates with scholars based in France, Switzerland and Germany. Ronald A. Asherson's co-authors include Jean‐Pierre Cazenave, L. Grunebaum, F Oberling, A. Faradji, Jean‐Pierre Bergerat, A. Bohbot, Jacques Bartholeyns, Philippe Poindron, Alice Eischen and Serge Dumont and has published in prestigious journals such as European Heart Journal, The Journal of Urology and Drugs.

In The Last Decade

Ronald A. Asherson

19 papers receiving 207 citations

Peers

Countries citing papers authored by Ronald A. Asherson

Since Specialization

Citations

This map shows the geographic impact of Ronald A. Asherson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald A. Asherson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald A. Asherson more than expected).

Fields of papers citing papers by Ronald A. Asherson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald A. Asherson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald A. Asherson. The network helps show where Ronald A. Asherson may publish in the future.

Co-authorship network of co-authors of Ronald A. Asherson

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald A. Asherson. A scholar is included among the top collaborators of Ronald A. Asherson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald A. Asherson. Ronald A. Asherson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phospholipid-Binding Antibodies 2020 ·SPIRE - Sciences Po Institutional REpository ·(unknown), (unknown), Graham R.V. Hughes, Ronald A. Asherson	0
2	Impaired inhibition of P2Y12 by clopidogrel is a major determinant of cardiac death in diabetes mellitus patients treated by percutaneous coronary intervention 2011 ·Atherosclerosis ·Soraya El Ghannudi, Patrick Ohlmann, Laurence Jesel, (unknown), (unknown), (unknown), Ronald A. Asherson, Christian Gachet, Olivier Morel	22
3	Nicht-okklusive Darmischämie als Komplikation der Hämodialysebehandlung 2008 ·DMW - Deutsche Medizinische Wochenschrift ·Martin Zeier, Ted R. Hupp, Ronald A. Asherson, M. Rambausek, E Ritz	3
4	In vitro evaluation of Haemonetics MCS+ apheresis platelet concentrates treated with photochemical pathogen inactivation following plasma volume reduction using the INTERCEPT Preparation Set 2005 ·Vox Sanguinis ·Hervé Isola, Daniel Kientz, Boris Aleil, (unknown), John A. Weil, Ronald A. Asherson, (unknown), L. Lin, V. Mayaudon, Jean‐Pierre Cazenave	9
5	Effect of Insulin on von Willebrand Factor Release in Normal and Diabetic Subjects: In Vivo and In Vitro Studies 2001 ·Hormone and Metabolic Research ·Laurence Kessler, Agnes M. Azimzadeh, Ronald A. Asherson, G. Coumaros, Nabil Chakfé, (unknown), C. Koehl, Jean‐Pierre Cazenave, (unknown), M. Pinget	3
6	Sensitivity and long‐term prognostic value of cardiac troponin‐i increase shortly after percutaneous transluminal coronary angioplasty 1998 ·Clinical Cardiology ·P Attali, Boris Aleil, (unknown), (unknown), Ronald A. Asherson, (unknown), (unknown), Jean‐Pierre Cazenave	25
7	Large scale isolation of human blood monocytes by continuous flow centrifugation leukapheresis and counterflow centrifugation elutriation for adoptive cellular immunotherapy in cancer patients 1994 ·Journal of Immunological Methods ·A. Faradji, A. Bohbot, (unknown), (unknown), Serge Dumont, Ronald A. Asherson, Y. Piémont, Alice Eischen, Jean‐Pierre Bergerat, Jacques Bartholeyns, Philippe Poindron, (unknown), F Oberling	58
8	Variation in von Willebrand's Factor according to the treatment of acute myocardial infarction: physiopathological and clinical implications 1994 ·European Heart Journal ·(unknown), J. M. Mossard, R Arbogast, Ronald A. Asherson, L. Grunebaum, G Roul, P Bareiss, (unknown), Jean‐Pierre Cazenave, A Sacrez	5
9	Anticorps antiphospholipides (aPL): détection et signification clinique 1992 ·La Revue de Médecine Interne ·L. Grunebaum, (unknown), Ronald A. Asherson, J.-M. Freyssinet, Joëlle Goetz, M Imler, Jean‐Pierre Cazenave	3
10	Hemostatic changes in human adoptive immunotherapy with activated blood monocytes or derived macrophages 1992 ·Annals of Hematology ·Ronald A. Asherson, A. Faradji, L. Grunebaum, A. Bohbot, (unknown), Jean‐Pierre Bergerat, Jean‐Pierre Cazenave, F Oberling	5
11	Electrophoretic Studies on Molecular Defects of von Willebrand Factor and Platelet Glycoprotein llb-llla with Antibodies Produced in Egg Yolk from Laying Hens 1992 ·Pathophysiology of Haemostasis and Thrombosis ·Florence Toti, Christian Gachet, Philippe Ohlmann, A Stierlé, L. Grunebaum, Ronald A. Asherson, Jean‐Pierre Cazenave	10
12	DNA amplification of HIV genome in hemophiliacs and in newborns from seropositive mothers 1991 ·Annals of Hematology ·C de la Salle, (unknown), (unknown), B. Guy, (unknown), Ronald A. Asherson, L. Grunebaum, Philipp Lutz, Marialuisa Partisani, Jean-Marie Lang, (unknown), Jean‐Pierre Cazenave	2
13	Novel point mutations leading to type 1 antithrombin deficiency and thrombosis 1991 ·British Journal of Haematology ·R.J. Olds, David A. Lane, H. Ireland, Giuseppe Leone, Valerio De Stefano, Ronald A. Asherson, Jean‐Pierre Cazenave, Swee Lay Thein	15
14	The catalytic role of anionic phospholipids in the activation of protein C by factor Xa and expression of its anticoagulant function in human plasma 1991 ·Blood Coagulation & Fibrinolysis ·J.-M. Freyssinet, (unknown), Catherine Ravanat, L. Grunebaum, (unknown), Jean‐Pierre Cazenave, Ronald A. Asherson	16
15	Dermatite de contact par cathéter intraveineux périphérique à embase métallique 1991 ·Annales Françaises d Anesthésie et de Réanimation ·Sandy Vrignaud, (unknown), Ronald A. Asherson	2
16	Déficits congénitaux dans les systèmes anticoagulants naturels responsables de maladies thromboemboliques récidivantes 1991 ·La Revue de Médecine Interne ·L. Grunebaum, Ronald A. Asherson, J.-M. Freyssinet, Jean‐Pierre Cazenave	2
17	Apheresis-Elutriation Program for Adoptive Immunotherapy with Autologous Activated Monocytes in Cancer Patients 1991 ·The International Journal of Artificial Organs ·A. Faradji, A. Bohbot, (unknown), Serge Dumont, Alice Eischen, Ronald A. Asherson, A Stierlé, Gilles Folléa, M. Eber, Jean‐Pierre Bergerat, Jacques Bartholeyns, Philippe Poindron, (unknown), Heiner Frost, F Oberling	15
18	A randomized study of combined 5-fluorouracil and plasma perfusion over protein A-Sepharose in human advanced colorectal carcinoma 1990 ·Biotherapy ·A. Faradji, A. Bohbot, (unknown), J P Arnaud, (unknown), Joëlle Goetz, Ronald A. Asherson, J.P. Bergerat, P. Dufour, Gilles Folléa, Jean‐Pierre Cazenave, M Adloff, F Oberling	3
19	Clinical Experience with Cefotaxime in Internal Medicine between 1981 and 1984 1988 ·Drugs ·P. M. Shah, Ronald A. Asherson, W. Stille	4
20	Biological and Clinical Heterogeneity of Lupus and Lupus-Like Anticoagulant in Fifty-Seven Patients 1988 ·The Journal of Urology ·M.H. Horellou, M.H. Aurousseau, MC Boffa, (unknown), Ronald A. Asherson, M Samama	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact